The Zhitong Finance App learned that Jingfeng Medical-B (02675.HK) offered shares from December 30, 2025 to January 5, 2026. The company plans to issue 277.22 million H shares, 10% of which will be publicly sold in Hong Kong. The sale price is HK$43.24 per share, raising capital of nearly HK$1.2 billion, 100 shares per lot, and an entry fee of HK$4367.6 per lot. Jingfeng Medical is expected to be listed for sale on January 8, with Morgan Stanley and GF Securities as co-sponsors. According to the data, as of 10 p.m. on January 4, Jingfeng Medical had temporarily obtained a margin loan of HK$47.87 billion from the brokerage firm. Based on the amount raised in the public sale of HK$120 million, it had oversubscribed 398 times.

The Zhitong Finance App learned that Jingfeng Medical-B (02675.HK) offered shares from December 30, 2025 to January 5, 2026. The company plans to issue 277.22 million H shares, 10% of which will be publicly sold in Hong Kong. The sale price is HK$43.24 per share, raising capital of nearly HK$1.2 billion, 100 shares per lot, and an entry fee of HK$4367.6 per lot. Jingfeng Medical is expected to be listed for sale on January 8, with Morgan Stanley and GF Securities as co-sponsors. According to the data, as of 10 p.m. on January 4, Jingfeng Medical had temporarily obtained a margin loan of HK$47.87 billion from the brokerage firm. Based on the amount raised in the public sale of HK$120 million, it had oversubscribed 398 times.